Table 2. Demographic and baseline characteristics of the patients by sICH per ECASS II criteria.
| variables | sICH (N = 44) | Non-sICH(N = 1084) | p |
|---|---|---|---|
| Age (year) | 66.73±9.04 | 63.35±11.41 | 0.0918 |
| <70 | 22(50.00) | 689(63.56) | 0.0677 |
| ≧70 | 22(50.00) | 395(36.44) | |
| Gender (male) | 24(54.55) | 664(61.25) | 0.3711 |
| Hypertension | 28(63.64) | 639(58.95) | 0.5352 |
| Diabetes | 9(20.45) | 187(17.25) | 0.5825 |
| mRS 0–2 before stroke | 44(100.00) | 1062(97.97) | 0.3399 |
| NIHSS on admission | 15(12–20.00) | 11(7–16) | 0.0002 |
| 0–14 | 21(47.73) | 749(69.10) | 0.0041 |
| 15–20 | 13(29.55) | 228(21.03) | |
| >20 | 10(22.73) | 107(9.87) | |
| SBP on admission (mm Hg) | 146.48±17.92 | 148.09±21.07 | 0.5893 |
| DBP on admission (mm Hg) | 87.00±11.56 | 85.90±12.69 | 0.7532 |
| Serum glucose on admission (mmol/L) | 8.88±3.81 | 7.67±2.99 | 0.0150 |
| ≦9.0 | 28(63.64) | 880(81.18) | 0.0040 |
| >9.0 | 16(36.36) | 204(18.82) | |
| Preexisting antihypertensive treatment | 17(38.64) | 415(38.28) | 0.9624 |
| Preexisting anticoagulant treatment | 0(0.00) | 19(1.75) | 0.3758 |
| Preexisting antiplatelet treatment | 10(22.73) | 148(13.65) | 0.0891 |
| Early infarct signs on admission CT head scan | 2(4.55) | 59(5.44) | 1.0000 |
| Hyper dense middle cerebral artery sign on admission CT | 5(11.36) | 72(6.64) | 0.3615 |
| Alteplase dose (mg/kg body weight) | 0.90(0.80–0.90) | 0.90(0.86–0.90) | 0.0482 |
| Onset to needle time (hours) | 2.88(2.41–3.55) | 2.83(2.33–3.25) | 0.2754 |
| Onset to needle time >3 h | 20(45.45) | 354(32.66) | 0.0771 |
| Stroke subtype | |||
| Large-artery atherosclerosis | 15(34.09) | 591(54.52) | <.0001 |
| Small-vessel occlusion | 0(0.00) | 117(10.79) | |
| Cardioembolism | 23(52.27) | 198(18.27) | |
| Other | 6(13.64) | 178(16.42) |
Continuous variables: median with interquartile range (IQR) and P values per the Mann-Whitney U test. Categorical variables: proportions (%) and P values per the Pearson χ2 test.
age; ECASS II, the European Cooperative Acute Strokage; ECASS II, the European Cooperative Acute Stroke Study II; NIHSS, National Institutes of Health Stroke Scale; BP, blood pressure; mRS, modified Rankin Scale